Aso International Inc
Aso International Inc provides medical equipment, supplies, and distribution services in the healthcare sector.
Business. Aso International Inc (9340.T) is a Japanese healthcare company engaged in the medical equipment, supplies, and distribution industry. The firm operates primarily through the sale of medical products and is headquartered in Japan. It is listed on the Tokyo Stock Exchange. Specific details regarding operating segments and geographic revenue mix are not disclosed in the available data.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Aso International Inc (9340.T) is a Japanese healthcare company engaged in the medical equipment, supplies, and distribution industry. The firm operates primarily through the sale of medical products and is headquartered in Japan. It is listed on the Tokyo Stock Exchange. Specific details regarding operating segments and geographic revenue mix are not disclosed in the available data.
Aso International Inc maintains a strong liquidity position, with a current ratio of 7.01, indicating a high ability to meet short-term obligations. The company holds JPY 1,873,428,000 in cash and equivalents, representing 64.6% of its total assets, and has no long-term debt, which further supports its liquidity profile. This liquidity is supported by a total equity of JPY 2,588,630,000, with total liabilities at JPY 369,765,000, resulting in a debt-to-equity ratio of 0.
In terms of profitability, Aso International Inc reports a return on equity (ROE) of 3.97% and a return on assets (ROA) of 3.47%. These figures are below the industry median for ROE and ROA in the Medical Equipment, Supplies & Distribution sector, suggesting that the company is underperforming relative to its peers in terms of capital efficiency and asset utilization.
The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic breakdown provided in the available data. This lack of geographic diversification may expose the company to regional economic or regulatory risks, though the extent of such exposure is not quantified in the available data.
Looking ahead, Aso International Inc is projected to grow its revenue from JPY 8,743,350,000 in the current fiscal year to JPY 4,100,000,000 in the next fiscal year, representing a decline of 53.0%. This significant drop in revenue expectations may be attributed to market saturation, competitive pressures, or a shift in demand for its products and services.
The company's risk profile is characterized by low liquidity and dilution risk, with no immediate filing-based flags detected. The absence of long-term debt and the high cash reserves reduce the likelihood of financial distress. However, the potential for dilution remains low, as the number of shares outstanding has not changed between basic and diluted shares.
Recent events, including analyst estimates and actual performance, indicate a mixed outlook. The last actual EPS was 44.90 JPY, compared to a mean estimate of 50.00 JPY, suggesting a slight underperformance. Similarly, the last actual revenue of JPY 3,796,450,000 fell short of the mean estimate of JPY 4,100,000,000, indicating a need for the company to address potential operational or market challenges.
- Aso International Inc has a strong liquidity position with a current ratio of 7.01 and no long-term debt.
- The company's ROE and ROA are below industry medians, indicating underperformance in capital efficiency and asset utilization.
- Revenue is concentrated in a single business segment, with no geographic diversification disclosed.
- Analyst estimates suggest a significant decline in revenue for the next fiscal year, from JPY 8.74 billion to JPY 4.1 billion.
- The company faces low liquidity and dilution risk, with no immediate filing-based flags detected.
Bull / Bear case
Generated · model-assistedAso International maintains a zero long-term debt balance, eliminating interest expense and financial distress risk.
Revenue grew to 3.8 billion JPY in FY2025, demonstrating consistent top-line expansion over recent periods.
Return on equity of 3.97% outperforms the 1.42% median return for the broader medical equipment sector.
The four-year revenue CAGR of -0.6% suggests long-term top-line stagnation despite recent positive trends.
In focus — financials by report
Revenue ¥1.02B, +7,7% YoY; Operating income +11,6% YoY.
- ▍Revenue ¥1.02B, +7,7% YoY
- ▍Operating income +11,6% YoY
- ▍Net income +2,9% YoY
- ▍Net margin 12.3%
Revenue ¥1.00B, +9,2% YoY; Operating income +10,6% YoY.
- ▍Revenue ¥1.00B, +9,2% YoY
- ▍Operating income +10,6% YoY
- ▍Net income +40,1% YoY
- ▍Net margin 11.0%
Revenue ¥979.5M, +2,6% YoY; Operating income −2,6% YoY.
- ▍Revenue ¥979.5M, +2,6% YoY
- ▍Operating income −2,6% YoY
- ▍Net income −19,9% YoY
- ▍Net margin 13.4%
Revenue ¥952.9M, +9,0% YoY; Operating income +12,8% YoY.
- ▍Revenue ¥952.9M, +9,0% YoY
- ▍Operating income +12,8% YoY
- ▍Net income +3,4% YoY
- ▍Net margin 11.1%
Revenue ¥947.7M; Operating income ¥152.2M.
- ▍Revenue ¥947.7M
- ▍Operating income ¥152.2M
- ▍Net margin 12.9%
Revenue ¥916.3M; Operating income ¥135.9M.
- ▍Revenue ¥916.3M
- ▍Operating income ¥135.9M
- ▍Net margin 8.6%
Revenue ¥955.1M; Operating income ¥184.4M.
- ▍Revenue ¥955.1M
- ▍Operating income ¥184.4M
- ▍Net margin 17.2%
Revenue ¥874.3M; Operating income ¥149.1M.
- ▍Revenue ¥874.3M
- ▍Operating income ¥149.1M
- ▍Net margin 11.7%
Revenue ¥3.80B, +7,1% YoY; Operating income +16,5% YoY.
- ▍Revenue ¥3.80B, +7,1% YoY
- ▍Operating income +16,5% YoY
- ▍Net income +13,5% YoY
- ▍Free cash flow −33,9% YoY
- ▍Net margin 11.6%
Revenue ¥3.54B, +11,1% YoY; Operating income +7,3% YoY.
- ▍Revenue ¥3.54B, +11,1% YoY
- ▍Operating income +7,3% YoY
- ▍Net income +14,3% YoY
- ▍Free cash flow +44,8% YoY
- ▍Net margin 10.9%
Revenue ¥3.19B, +2,4% YoY; Operating income −0,5% YoY.
- ▍Revenue ¥3.19B, +2,4% YoY
- ▍Operating income −0,5% YoY
- ▍Net income −3,9% YoY
- ▍Free cash flow −43,3% YoY
- ▍Net margin 10.6%
Valuation TTM
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 50,00 |
| Revenue | —no estimate | —no estimate | 4,1B JPY |
| Operating income | —no estimate | —no estimate | —no estimate |
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Return On Assetsnet_income / total_assets
- Aso International Inc Market data — financials · 2026-05-27
- Aso International Inc Market data — analyst estimates · 2026-05-27